Abstract
Although tyrosine sulfation is a post-translational modification widespread across multicellular eukaryotes1, its biological functions remain largely unknown. This is in part due to the difficulties of synthesizing selectively sulfated proteins. Here we report the selective incorporation of sulfotyrosine into proteins in bacteria by genetically encoding the modified amino acid in response to the amber nonsense codon TAG. Moreover, we show that this strategy enables direct expression in Escherichia coli of sulfo-hirudin, previously inaccessible through recombinant methods. The affinity of sulfo-hirudin toward human thrombin is enhanced more than tenfold over that of desulfo-hirudin, suggesting that sulfo-hirudin may offer clinical advantages for use as an anticoagulant2. This general approach to the biosynthesis of sulfated proteins should facilitate further study and application of tyrosine sulfation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Moore, K.L. The biology and enzymology of protein tyrosine O-sulfation. J. Biol. Chem. 278, 24243–24246 (2003).
Di Nisio, M., Middeldorp, S. & Buller, H.R. Direct thrombin inhibitors. N. Engl. J. Med. 353, 1028–1040 (2005).
Kehoe, J.W. & Bertozzi, C.R. Tyrosine sulfation: a modulator of extracellular protein-protein interactions. Chem. Biol. 7, R57–R61 (2000).
Preobrazhensky, A.A. et al. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J. Immunol. 165, 5295–5303 (2000).
Farzan, M. et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96, 667–676 (1999).
Farzan, M. et al. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J. Biol. Chem. 277, 29484–29489 (2002).
Veldkamp, C.T., Seibert, C., Peterson, F.C., Sakmar, T.P. & Volkman, B.F. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). J. Mol. Biol. 359, 1400–1409 (2006).
Fong, A.M., Alam, S.M., Imai, T., Haribabu, B. & Patel, D.D. CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 277, 19418–19423 (2002).
Somers, W.S., Tang, J., Shaw, G.D. & Camphausen, R.T. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103, 467–479 (2000).
Dong, J.F., Li, C.Q. & Lopez, J.A. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 33, 13946–13953 (1994).
Bagdy, D., Barabas, E., Graf, L., Petersen, T.E. & Magnusson, S. Hirudin. Methods Enzymol. 45, 669–678 (1976).
Choe, H. et al. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114, 161–170 (2003).
Xiang, S.H. et al. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J. Virol. 79, 6068–6077 (2005).
Kirano, Y., Kimura, T. & Sakakibara, S. Total synthesis of porcine cholecystokinin-33 (CCK-33). J. Chem. Soc. Chem. Commun., 323–325 (1987).
Muramatsu, R. et al. Enzymic O-sulfation of tyrosine residues in hirudins by sulfotransferase from Eubacterium A-44. Eur. J. Biochem. 223, 243–248 (1994).
Young, T. & Kiessling, L.L. A strategy for the synthesis of sulfated peptides. Angew. Chem. Int. Edn Engl. 41, 3449–3451 (2002).
Stone, S.R. & Hofsteenge, J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 25, 4622–4628 (1986).
Wang, L., Brock, A., Herberich, B. & Schultz, P.G. Expanding the genetic code of Escherichia coli. Science 292, 498–500 (2001).
Chin, J.W. et al. An expanded eukaryotic genetic code. Science 301, 964–967 (2003).
Zhang, Z. et al. Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 8882–8887 (2004).
Bose, M., Groff, D., Xie, J., Brustad, E. & Schultz, P.G. The incorporation of a photoisomerizable amino acid into proteins in E. coli. J. Am. Chem. Soc. 128, 388–389 (2006).
Wolfender, J.L. et al. Identification of tyrosine sulfation in Conus pennaceus conotoxins alpha-PnIA and alpha-PnIB: further investigation of labile sulfo- and phosphopeptides by electrospray, matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry. J. Mass Spectrom. 34, 447–454 (1999).
Nemeth-Cawley, J.F., Karnik, S. & Rouse, J.C. Analysis of sulfated peptides using positive electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 36, 1301–1311 (2001).
Markwardt, F. Hirudin as alternative anticoagulant–a historical review. Semin. Thromb. Hemost. 28, 405–414 (2002).
Braun, P.J., Dennis, S., Hofsteenge, J. & Stone, S.R. Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin. Biochemistry 27, 6517–6522 (1988).
Ryu, Y. & Schultz, P.G. Efficient incorporation of unnatural amino acids into proteins in Escherichia coli. Nat. Methods 3, 263–265 (2006).
Cha, S. Tight-binding inhibitors–III. A new approach for the determination of competition between tight-binding inhibitors and substrates–inhibition of adenosine deaminase by coformycin. Biochem. Pharmacol. 25, 2695–2702 (1976).
Komatsu, Y., Misawa, S., Sukesada, A., Ohba, Y. & Hayashi, H. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3. Biochem. Biophys. Res. Commun. 196, 773–779 (1993).
Szedlacsek, S.E. & Duggleby, R.G. Kinetics of slow and tight-binding inhibitors. Methods Enzymol. 249, 144–180 (1995).
Velan, T. & Chandler, W.L. Effects of surgical trauma and cardiopulmonary bypass on active thrombin concentrations and the rate of thrombin inhibition in vivo. Pathophysiol. Haemost. Thromb. 33, 144–156 (2003).
Acknowledgements
We thank Jianming Xie for providing synthetase libraries for this project and Youngha Ryu for providing the pSup vector. C.C.L. thanks Jianming Xie, Eric Brustad, Vaughn Smider, Wenshe Liu, Jacob Pinnas and Michael Jahnz for invaluable discussions and advice. C.C.L. gratefully acknowledges the Fannie and John Hertz Foundation and the National Science Foundation for predoctoral fellowships. This research was generously supported by the USNational Institutes of Health (GM62159).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Sulfotyrosine dependent expression of Z-domain. (PDF 1726 kb)
Supplementary Fig. 2
Mass spectra characterization of sulfo-hirudin. (PDF 301 kb)
Supplementary Fig. 3
Sulfotyrosine dependent expression of sulfo-hirudin. (PDF 403 kb)
Supplementary Table 1
Thrombin inhibition by hirudin kinetic constants. (PDF 50 kb)
Rights and permissions
About this article
Cite this article
Liu, C., Schultz, P. Recombinant expression of selectively sulfated proteins in Escherichia coli. Nat Biotechnol 24, 1436–1440 (2006). https://doi.org/10.1038/nbt1254
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/nbt1254
This article is cited by
-
Titrating bacterial growth and chemical biosynthesis for efficient N-acetylglucosamine and N-acetylneuraminic acid bioproduction
Nature Communications (2020)
-
Genetically encoded protein sulfation in mammalian cells
Nature Chemical Biology (2020)
-
Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis
Scientific Reports (2020)
-
A new path to tyrosine sulfation
Nature Chemical Biology (2020)
-
Functional genetic encoding of sulfotyrosine in mammalian cells
Nature Communications (2020)


